Format

Send to

Choose Destination
See comment in PubMed Commons below
Am J Bioeth. 2015;15(4):4-10. doi: 10.1080/15265161.2015.1010993.

Selecting the right tool for the job.

Author information

1
a New York University Langone Medical Center.

Abstract

There are competing ethical concerns when it comes to designing any clinical research study. Clinical trials of possible treatments for Ebola virus are no exception. If anything, the competing ethical concerns are exacerbated in trying to find answers to a deadly, rapidly spreading, infectious disease. The primary goal of current research is to identify experimental therapies that can cure Ebola or cure it with reasonable probability in infected individuals. Pursuit of that goal must be methodologically sound, practical and consistent with prevailing norms governing human subjects research. Some maintain that only randomized controlled trials (RCTs) with a placebo or standard-of-care arm can meet these conditions. We maintain that there are alternative trial designs that can do so as well and that sometimes these are preferable to RCTs.

KEYWORDS:

Ebola treatment trials; adaptive trial design; cluster randomized designs; compassionate access; elimination of inferior treatments; expanded access; international research; placebo controls; randomized controlled trials (RCT); research ethics; selection trials; sequential designs; standard of care controls

PMID:
25856591
DOI:
10.1080/15265161.2015.1010993
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Support Center